Skip to content
healthcare.dev
Get a free key

ORPHENADRINE CITRATE

NDC 82868-040, ORPHENADRINE CITRATE, tablet, extended release, from Northwind Health Company, LLC.

Product NDC
82868-040
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82868-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE100 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
82868-040-148286800401414 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-040-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/106be130-b4f8-5ca1-e063-6294a90a1590

Use it

Look up 82868-040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82868-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82868-040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.